Purpose of review
The passenger leukocyte hypothesis predicts that after transplantation, donor antigen (Ag)-presenting cells (APCs) from the graft present donor MHC molecules to directly alloreactive T cells in lymphoid organs. However, in certain transplantation models, recent evidence contradicts this long-standing concept. New findings demonstrate that host, instead of donor, APCs play a prominent role in allo-sensitization against donor MHC molecules via the semi-direct pathway. A similar mechanism operates in development of T-cell split tolerance to non-inherited maternal Ags (NIMAs).
Recent findings
Following fully-mismatch skin or heart transplantation in mice, no or extremely few donor migrating APCs (i.e. conventional dendritic cells, DCs) are detected in the draining lymphoid organs. Instead, recipient DCs that have captured donor extracellular vesicles (EVs, i.e. exosomes) carrying donor MHC molecules and APC co-stimulatory signals, present donor MHC molecules to directly allo-reactive T cells. This semi-direct pathway can also give rise to a form of “split” tolerance during chronic alloantigen exposure, since indirectly alloreactive T helper cells and directly alloreactive T cell effectors are differentially impacted by host DCs “cross-dressed” with EVs/exosomes derived from maternal microchimerism.
Summary
Acquisition by recipient APCs of donor exosomes (and likely other EVs) released by passenger leukocytes or the graft, explains the potent T-cell allo-sensitization against donor MHC molecules, in absence or presence of few passenger leukocytes in lymphoid organs. It also provides the basic mechanism and in vivo relevance of the elusive semi-direct pathway. Its degree of coordination with the allopeptide –specific, indirect pathway of T cell help may determine whether semi-direct allopresentation results in a sustained, effective, acute rejection response, or rather, in abortive acute rejection and “split” tolerance.